Literature DB >> 27817041

Evidence for a role of decitabine in the treatment of myeloid sarcoma.

Max Gornicec1, Albert Wölfler1, Susanne Stanzel2, Heinz Sill1, Armin Zebisch3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27817041     DOI： 10.1007/s00277-016-2870-0

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  10 in total

1.  Activity of decitabine in pericardial myeloid sarcoma.

Authors:  Dorothea Evers; Brigitte M A M Bär; Martin Gotthardt; Walter J F M van der Velden
Journal:  Int J Hematol       Date:  2018-05-19       Impact factor: 2.490

Review 2.  Target Therapy for Extramedullary Relapse of FLT3-ITD Acute Myeloid Leukemia: Emerging Data from the Field.

Authors:  Andrea Duminuco; Cinzia Maugeri; Marina Parisi; Elisa Mauro; Paolo Fabio Fiumara; Valentina Randazzo; Domenico Salemi; Cecilia Agueli; Giuseppe Alberto Palumbo; Alessandra Santoro; Francesco Di Raimondo; Calogero Vetro
Journal:  Cancers (Basel)       Date:  2022-04-27       Impact factor: 6.575

3.  Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration.

Authors:  Veronica Caraffini; Bianca Perfler; Johannes Lorenz Berg; Barbara Uhl; Silvia Schauer; Karl Kashofer; Nassim Ghaffari-Tabrizi-Wizsy; Herbert Strobl; Albert Wölfler; Gerald Hoefler; Heinz Sill; Armin Zebisch
Journal:  Blood       Date:  2018-01-02       Impact factor: 22.113

4.  An unusual type of myeloid sarcoma localization following myelofibrosis: A case report and literature review.

Authors:  Nicola Orofino; Daniele Cattaneo; Cristina Bucelli; Loredana Pettine; Sonia Fabris; Umberto Gianelli; Nicola Stefano Fracchiolla; Agostino Cortelezzi; Alessandra Iurlo
Journal:  Leuk Res Rep       Date:  2017-07-27

5.  Long-Lasting Remission in De Novo Breast Myeloid Sarcoma Treated with Decitabine and Radiotherapy.

Authors:  Carla Minoia; Vincenza de Fazio; Giovanni Scognamillo; Anna Scattone; Nicola Maggialetti; Cristina Ferrari; Attilio Guarini
Journal:  Diagnostics (Basel)       Date:  2019-07-27

6.  Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency.

Authors:  Jinhuan Wang; Zhaoyi Miao; Yanan Jiang; Ping Zou; Weiming Li; Xiaoqiong Tang; Yangyang Lv; Donghui Xing; Shi Chen; Fengchun Yang; Mingjiang Xu; Zeng Cao; Haitao Wang; Zhigang Zhao
Journal:  Oncol Lett       Date:  2020-03-27       Impact factor: 2.967

7.  Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine.

Authors:  Kazuya Sato; Nodoka Tsukada; Junki Inamura; Shigetsuna Komatsu; Keisuke Sato; Masayo Yamamoto; Motohiro Shindo; Kentaro Moriichi; Yusuke Mizukami; Mikihiro Fujiya; Yoshihiro Torimoto; Toshikatsu Okumura
Journal:  Case Rep Hematol       Date:  2021-04-21

8.  Bladder Myeloid Sarcoma with TP53 mutated Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap syndrome: Response to Decitabine-Venetoclax regimen.

Authors:  Nikeeta Mandhan; Farah Yassine; Ke Li; Talha Badar
Journal:  Leuk Res Rep       Date:  2021-12-14

9.  [Isolated myeloid sarcoma].

Authors:  J Wang; X J Huang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-10-14

10.  Serial Analysis and Comparison of Mutation Profiles in Decitabine-treated Myeloid Sarcoma and Subsequent Acute Myeloid Leukemia Using Next-Generation Sequencing.

Authors:  Hee Sue Park; Seung Myoung Son; Jihyun Kwon
Journal:  Ann Lab Med       Date:  2022-09-01       Impact factor: 4.941
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.